CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Pharmaceutical Product Development, Incorporated Company Snapshot
Business Description:
Pharmaceutical Product Development, Incorporated operates in the Commercial physical research sector. Pharmaceutical Product Development, Inc. (PPD) is a global contract research organization providing drug discovery, development and lifecycle management services. The Company's clients and partners include pharmaceutical, biotechnology, medical device, academic, non-profit and government organizations. Its development services include preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, as well as bioanalytical, good manufacturing practices (cGMP), global central laboratory and vaccines and biologics laboratory services. It also offers support, such as medical information, patient compliance programs, patient and disease registry programs, product safety and pharmacovigilance, standard response document development, observational studies, Phase IV monitored studies and prescription-to-over-the-counter (Rx to OTC), programs. It operates in two segments: Clinical Development Services and Laboratory Services. In our complete report available for purchase the company is compared to: PAREXEL International Corporation, Charles River Laboratories International Inc and Covance Inc..
   
   
 
  Stock Performance Chart for Pharmaceutical Product Development, Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (12/2/2011): 33.19
(Figures in U.S. Dollars)
1 Week 0.2%   13 Weeks 0.4%  
4 Weeks 6.5%   52 Weeks 28.2%  
 
Pharmaceutical Product Development, Incorporated Key Data:
  Ticker: PPDI Country: UNITED STATES
  Exchanges: NAS FRA Major Industry: Miscellaneous
    Sub Industry: Medical Services
  2010 Sales 1,470,570,000
(Year Ending Jan 2011).
Employees: 11,000
  Currency: U.S. Dollars Market Cap: N/A
  Fiscal Yr Ends: December Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.